Financial Incentives to Improve Medication Adherence

Not Applicable

Completed

• Conditions: Schizo Affective Disorder; Bipolar Disorder; Schizophrenia; Depression
• Interventions: Other: Wellth - Financial Incentives

• Registration Number: NCT04191876
• Lead Sponsor: Northwell Health

Brief Summary

Medication adherence is a challenge in all of medicine and is associated with multiple negative outcomes. Strategies to better measure and enhance adherence to medication are urgent and necessary to minimize unwanted health outcomes, hospitalizations, poorer quality of life and excessive costs for individuals, insurers and caregivers. Recently, behavioral economics-based approaches have emerged as a promising tool to address this unmet need, but its effectiveness in oral antipsychotic treatment remains to be assessed. For this project, investigators will use an app that offers financial incentives to increase compliance for patients with chronic diseases. Investigators intend to enroll 25 patients in a pilot project to assess feasibility of offering financial incentives to improve medication adherence in severe mental illness.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-11-01
• Study First Submitted: 2019-12-02
• Study First Submitted QC: 2019-12-05
• Study First Posted: 2019-12-10
• Primary Completion: 2020-05-30
• Study Completion: 2022-03-02
• Status Verified: 2023-09
• Last Update Submitted: 2023-09-15
• Last Update Posted: 2023-09-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

1. Psychiatric patients with suspected or confirmed poor oral medication adherence.
2. Age 18-80 years old
3. English speaking, since the app being used is only available in English
4. Owning a Smartphone, since the app requires a Smartphone to work
5. Willing and able to participate.

Exclusion Criteria

1. Acute anger to self or others as per investigator assessment
2. Unwilling or unable to participate

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Active	Wellth - Financial Incentives	This study has only one arm. All patients enrolled will take part in the experimental arm.

Primary Outcome Measures

Name	Time	Method
Change in medication adherence rate	Between baseline and study completion (10 weeks)	Adherence rate will be measured as pills missed/pills prescribed

Trial Locations

Locations (1)

The Zucker Hillside Hospital; 🇺🇸 Glen Oaks, New York, United States